(±)-Fabesetron hydrochloride is a potent dual antagonist of 5-HT3 and 5-HT4 receptors, used for the inhibition of serotonin-induced acceleration of colonic transit and reduction of fecal pellet output in stress models; it effectively suppresses 5-HT- and 5-methoxytryptamine-induced diarrhea in fasted mice; additionally, it reduces delayed emesis caused by methotrexate (MTX) and decreases the number of emetic episodes in a dose-dependent manner.